We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

TherapeuticsMD Inc (TXMD) USD0.10

Sell:$0.46 Buy:$0.46 Change: $0.0213 (4.83%)
Market closed |  Prices as at close on 8 December 2021 | Switch to live prices |
Sell:$0.46
Buy:$0.46
Change: $0.0213 (4.83%)
Market closed |  Prices as at close on 8 December 2021 | Switch to live prices |
Sell:$0.46
Buy:$0.46
Change: $0.0213 (4.83%)
Market closed |  Prices as at close on 8 December 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products from pregnancy prevention through menopause. Its product pipeline includes IMVEXXY, BIJUVA, ANNOVERA, and prenatal vitamin product. The IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy due to menopause. Its BIJUVA (estradiol and progesterone) capsules is a bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. Its ANNOVERA (segesterone acetate (SA) and ethinyl estradiol (EE) vaginal system) is a one-year ring-shaped contraceptive vaginal system (CVS) and patient-controlled, procedure-free, reversible prescription contraceptive. Its prenatal vitamin products are sold under vitaMedMD and BocaGreenMD brands.

Contact details

Address:
951 W Yamato Rd Ste 220
BOCA RATON
33431-4440
United States
Telephone:
+1 (561) 9611900
Website:
https://www.therapeuticsmd.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TXMD
ISIN:
US88338N1072
Market cap:
$161.09 million
Shares in issue:
424.93 million
Sector:
Pharmaceuticals
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Hugh O Dowd
    President
  • Robert Finizio
    Chief Executive Officer, Director
  • James D'Arecca
    Chief Financial Officer
  • Michael Donegan
    Vice President - Finance, Chief Accounting Officer
  • Marlan Walker
    General Counsel
  • Mark Glickman
    Chief Business Officer
  • John Milligan
    Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.